EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urinary fatty acid binding protein 2 as a biomarker of intestinal injury in pediatric celiac disease

Vijay Mehta, Nidhi Kapoor, Chloe Milliron, Noah Stoeckel, Edwin Ballelos, Katrina Tiqui, Chirajyoti Deb, Bassam Abomoelak, Mary Schreck, Devendra Mehta

Frontiers in Pediatrics · 10.06.2026 · 14

DOI: 10.3389/fped.2026.1838294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 10.06.2026. Verfasst von Vijay Mehta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology, Orlando Health Arnold Palmer Hospital for Children, Orlando, FL, United States. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Celiac disease (CeD) is an autoimmune enteropathy triggered by gluten in genetically predisposed individuals, causing intestinal damage and impaired gut barrier integrity. Current diagnostic methods, such as serology and intestinal biopsy, are costly and invasive. Intestinal fatty acid binding protein (FABP2), exclusively expressed in the cytosol of mature enterocytes and released during injury, offers a potential non-invasive alternative biomarker. This study aimed to evaluate urinary FABP2 levels in pediatric patients undergoing gastrointestinal assessment or CeD follow-up to determine its potential as a non-invasive biomarker of intestinal integrity.

Methods

In this retrospective cross-sectional study, urinary FABP2 was measured in 103 pediatric patients evaluated for intestinal permeability using the lactulose/mannitol test. Based on serology and symptomatology, patients were categorized as controls ( n = 65), CeD on gluten-free diet (GFD) > 6 months ( n = 26), or active CeD ( n = 12). Associations between FABP2 levels, serology, symptoms, and diagnosis were analyzed.

Results

FABP2 levels were significantly elevated in active CeD patients (47.7 pg/mL) compared with controls (9.65 pg/mL) ( p < 0.05), but not in CeD patients on GFD (15.0 pg/mL). A receiver operating characteristic curve analysis confirmed the diagnostic potential of FABP2 as a biomarker for celiac disease (area under the curve = 0.7269; cutoff = 23.7 pg/mL; sensitivity = 66.7%, specificity = 76.9%).

Conclusion

Our findings indicate that urinary FABP2 reflects intestinal epithelial injury and may serve as a non-invasive biomarker for assessing gut integrity and disease activity in CeD. However, larger prospective studies with histological correlation are needed to validate its diagnostic utility.

Schlagwörter

Stichwörter der Autor:innen

autoimmune enteropathybiomarkerintestinal integrityintestinal permeability testleaky gutmucosal damage

Autor:innen und Institutionen

  • Pediatric Gastroenterology, Orlando Health Arnold Palmer Hospital for Children, Orlando, FL, United States.
  • Specialty Diagnostic Clinical and Translational Research Lab, Orlando Health Arnold Palmer Hospital for Children, Orlando, FL, United States.
  • University of Central Florida, Orlando, FL, United States.
  • Orlando Health Medical Group Pediatric Specialty Practice Resources, Orlando, FL, United States.

Zitieren

APA

Mehta, V., Kapoor, N., Milliron, C., Stoeckel, N., Ballelos, E., Tiqui, K., Deb, C., Abomoelak, B., Schreck, M., & Mehta, D. (2026). Urinary fatty acid binding protein 2 as a biomarker of intestinal injury in pediatric celiac disease. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1838294

Vancouver

Mehta V, Kapoor N, Milliron C, Stoeckel N, Ballelos E, Tiqui K, et al. Urinary fatty acid binding protein 2 as a biomarker of intestinal injury in pediatric celiac disease. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1838294

BibTeX
@article{Mehta2026,
  author = {Mehta, Vijay and Kapoor, Nidhi and Milliron, Chloe and Stoeckel, Noah and Ballelos, Edwin and Tiqui, Katrina and Deb, Chirajyoti and Abomoelak, Bassam and Schreck, Mary and Mehta, Devendra},
  title = {Urinary fatty acid binding protein 2 as a biomarker of intestinal injury in pediatric celiac disease},
  journal = {Frontiers in Pediatrics},
  year = {2026},
  volume = {14},
  doi = {10.3389/fped.2026.1838294}
}
Kostenlos starten →